SHE · Healthcare

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089)

Drug Manufacturers - Specialty & Generic

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $3.62B, P/E ratio is 18.00, net margin is -12.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 301089

Market cap
$3.62B
P/E ratio
18.00
Gross profit (TTM)
$108.23M
Net margin
-12.9%

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — FAQ

What is Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s market cap?

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a reported market cap of $3.62B (data as of 2026-03-28).

What is 301089's P/E ratio?

The price-to-earnings (P/E) ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) is 18.00 (data as of 2026-03-28).

Does Xinxiang Tuoxin Pharmaceutical Co.Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089). Check the MyAverix Finance app for the latest dividend data.

What sector is Xinxiang Tuoxin Pharmaceutical Co.Ltd. in?

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 301089 listed on?

301089 is listed on SHE.

What is Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s net margin?

Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) reports a net margin of -12.9% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play